Dr. Mohamed O. Othman, MD
Claim this profileBaylor College of Medicine
Studies Gastrointestinal Tumors
Studies Digestive System Tumors
17 reported clinical trials
27 drugs studied
Affiliated Hospitals
Clinical Trials Mohamed O. Othman, MD is currently running
Hybrid vs Non-Hybrid ESD
for Colorectal Lesions
This proposed trial will randomize 60 patients with a ≥20 mm large colorectal polyp to either undergo hybrid or non-hybrid ESD. For the primary comparison (hybrid vs non-hybrid ESD), the primary outcome will be procedure time. The study will further examine the safety and efficacy of hybrid ESD compared to non-hybrid ESD and investigate factors that may be associated with resection outcomes.
Recruiting1 award N/A
DMR
for Type 2 Diabetes
The Revita® system is being investigated to assess the efficacy of DMR versus Sham on improvement in Glycemic, Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled with insulin therapy. The purpose of this study is to demonstrate the efficacy and safety of the Fractyl DMR Procedure using the Revita® System compared to a sham. Subjects randomized to the DMR procedure will be followed per protocol till 48 weeks post treatment. Subjects in the Sham treatment arm will be offered cross over to receive the DMR treatment at 48 weeks and will be followed per protocol for 48 weeks post treatment.
Recruiting0 awards N/A7 criteria
More about Mohamed O. Othman, MD
Clinical Trial Related3 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Mohamed O. Othman, MD has experience with
- Endoscopic Submucosal Dissection
- Non-hybrid ESD
- Hybrid ESD
- OverStitch Sx
- ESD
- Endoscopic Submucosal Dissection (ESD)
Breakdown of trials Mohamed O. Othman, MD has run
Gastrointestinal Tumors
Digestive System Tumors
Gastrointestinal Neoplasms
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mohamed O. Othman, MD specialize in?
Mohamed O. Othman, MD focuses on Gastrointestinal Tumors and Digestive System Tumors. In particular, much of their work with Gastrointestinal Tumors has involved treating patients, or patients who are undergoing treatment.
Is Mohamed O. Othman, MD currently recruiting for clinical trials?
Yes, Mohamed O. Othman, MD is currently recruiting for 4 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Mohamed O. Othman, MD has studied deeply?
Yes, Mohamed O. Othman, MD has studied treatments such as Endoscopic Submucosal Dissection, Non-hybrid ESD, Hybrid ESD.
What is the best way to schedule an appointment with Mohamed O. Othman, MD?
Apply for one of the trials that Mohamed O. Othman, MD is conducting.
What is the office address of Mohamed O. Othman, MD?
The office of Mohamed O. Othman, MD is located at: Baylor College of Medicine, Houston, Texas 77030 United States. This is the address for their practice at the Baylor College of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.